Clinical trials: CIPN in Adjuvant Breast Cancer Patients, open to volunteers
CIPN in Adjuvant Breast Cancer Patients
Prevention of CIPN Using Compressive Therapy
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of treatment with taxanes and platinum-based drugs, significantly impacting the quality of life of oncology patients.
- Trial name
- CIPN (NCT06823440)
- Testing
- Compression using surgical gloves and compression knee socks
- Where
- Czechia
- Volunteers
- 100 people
- Sponsor
- Martina Lojova
CIPN - Chemotherapy-Induced Peripheral Neuropathy, CIPN
Multimodal Assessment of Cryotherapy for Paclitaxel-Induced Neuropathy
Female breast cancer patients receiving weekly paclitaxel-based chemotherapy are at risk of developing chemotherapy-induced peripheral neuropathy (CIPN), which may negatively affect quality of life and lead to treatment…
- Conditions
- CIPN - Chemotherapy-Induced Peripheral Neuropathy, CIPN, CIPN in Adjuvant Breast Cancer Patients, Chemotherapy Induced Peripheral Neuropathy
- Trial name
- NCT07780955
- Testing
- Cryotherapy
- Where
- 4 sites in Italy
- Volunteers
- 144 people
- Sponsor
- Azienda Sanitaria dell'Alto Adige